Screening for lung cancer with chest radiographs

JAMA

Volumn 306, Issue 17, 2011, Pages 1916-1918

  Sox, Harold C ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER RESEARCH; CANCER SCREENING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; EVIDENCE BASED MEDICINE; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LUNG CANCER; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; OVARY CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; THORAX RADIOGRAPHY;

EID: 80355148399     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1609     Document Type: Editorial

References (13)

1. Aberle DR, Adams AM, Berg CD, et al. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409.
2. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial [published online October 26, 2011]. JAMA. 2011;306(17):1865- 1873.
3. Humphrey LL, Teutsch S, Johnson M; U.S. Preventive Services Task Force. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the US Preventive Services Task Force. Ann Intern Med. 2004;140(9):740-753.
4. Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR. Lung cancer screening: the Mayo program. J Occup Med. 1986;28(8):746-750. (Pubitemid 16055356)
5. Prorok PC, Andriole GL, Bresalier RS, et al.; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials. 2000;21(6)(suppl):273S-309S.
6. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010;102(9):605-613.
7. Sox HC. Better evidence about screening for lung cancer. N Engl J Med. 2011;365(5):455-457.
8. Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006;98(11):748-756. (Pubitemid 43983298)
9. Hocking WG, Hu P, Oken MM, et al. PLCO Project Team. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. J Natl Cancer Inst. 2010;102(10):722-731.
10. Gauthier ML, Berman HK, Miller C, et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell. 2007;12(5):479-491. (Pubitemid 350046408)
11. Kerlikowske K, Molinaro AM, Gauthier ML, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst. 2010;102(9):627-637.
12. Song F, Altman DG, Glenny AM, Deeks JJ. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326(7387):472-477.
13. Ioannidis JP. Indirect comparisons: the mesh and mess of clinical trials. Lancet. 2006;368(9546):1470-1472. (Pubitemid 44634678)